- Home
- NVFY vs PRLD Comparison
NVFY vs PRLD Comparison
Compare NVFY & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- PRLD
- Stock Information
- Founded
- NVFY 2003
- PRLD 2016
- Country
- NVFY United States
- PRLD United States
- Employees
- NVFY N/A
- PRLD N/A
- Industry
- NVFY Home Furnishings
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- NVFY Consumer Discretionary
- PRLD Health Care
- Exchange
- NVFY Nasdaq
- PRLD Nasdaq
- Market Cap
- NVFY 36.8M
- PRLD 44.0M
- IPO Year
- NVFY N/A
- PRLD 2020
- Fundamental
- Price
- NVFY $4.76
- PRLD $1.25
- Analyst Decision
- NVFY
- PRLD Strong Buy
- Analyst Count
- NVFY 0
- PRLD 3
- Target Price
- NVFY N/A
- PRLD $4.00
- AVG Volume (30 Days)
- NVFY 1.9M
- PRLD 219.0K
- Earning Date
- NVFY 08-14-2025
- PRLD 11-05-2025
- Dividend Yield
- NVFY N/A
- PRLD N/A
- EPS Growth
- NVFY N/A
- PRLD N/A
- EPS
- NVFY N/A
- PRLD N/A
- Revenue
- NVFY $9,813,990.00
- PRLD $7,000,000.00
- Revenue This Year
- NVFY N/A
- PRLD N/A
- Revenue Next Year
- NVFY N/A
- PRLD N/A
- P/E Ratio
- NVFY N/A
- PRLD N/A
- Revenue Growth
- NVFY N/A
- PRLD N/A
- 52 Week Low
- NVFY $0.39
- PRLD $0.61
- 52 Week High
- NVFY $5.89
- PRLD $5.53
- Technical
- Relative Strength Index (RSI)
- NVFY 81.68
- PRLD 60.92
- Support Level
- NVFY $1.67
- PRLD $1.10
- Resistance Level
- NVFY $2.09
- PRLD $1.26
- Average True Range (ATR)
- NVFY 0.53
- PRLD 0.15
- MACD
- NVFY 0.31
- PRLD 0.00
- Stochastic Oscillator
- NVFY 73.23
- PRLD 81.13
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.